Celldex Therapeutics | CLDX - Pre Tax Profit

Stock Price
29.37
Daily Change
-0.17 -0.58%
Monthly
23.61%
Yearly
37.69%
Q1 Forecast
29.17

Celldex Therapeutics reported $-81.32M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Agenus USD -274.14M 80.46M Sep/2025
Amgen USD 3.92B 2.35B Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Celldex Therapeutics USD -81.32M 14.27M Dec/2025
Glaxosmithkline GBP 2.46B 569M Sep/2025
Nektar Therapeutics USD -37.05M 15.27M Sep/2024
Pfizer USD 3.33B 290M Sep/2025
Rigel Pharmaceuticals USD -1.03M 7.22M Jun/2024
Roche Holding CHF 4.79B 3.01B Jun/2025